The University of Colorado Division of Hematology invites you to a review of the 2018 American Society of Hematology Annual Meeting to be held at the Denver Museum of Nature and Science on January 26, 2019.
Updates will be provided by experts in lymphoma/chronic lymphocytic leukemia, multiple myeloma, acute myeloid leukemia, myeloproliferative neoplasms, CAR-T cell therapies, and coagulation disorders with a focus on latest treatment advances from ASH 2018 relevant to your clinical practice. Speakers will be from the UCHealth system as well as three guest speakers from the Mayo Clinic, in Rochester, Minnesota. The day will include panel discussions and interactive question answer sessions.
By the end of the review, attendees will be better equipped to:
Identify which patients with hematologic malignancy may benefit from specific targeted therapies.
Recognize myriad of presentations of patients with hematologic malignancy.
Identify higher risk patients with hematologic malignancy and know best available therapies for these patients. Recognize best current approach to patients requiring more aggressive treatments.
Prescribe individualized plans for patients with hematologic malignancies based on specific disease characteristics (genetics, molecular markers).
Manage complications of hematologic malignancies in an outpatient setting.
This conference is hosted by all of the UCHealth campuses. Further information can be found regarding our main Denver campus by visiting the University of Colorado Division of Hematology website and the UCHealth website for our Colorado Springs locations.
January 26, 2019
Denver Museum of Nature and Science
2001 Colorado Blvd
Denver, Colorado, 80205
Registration / Breakfast
Update on CLL
Dr. Sameer Parikh
Update on Lymphoma
Dr. Grzegorz Nowakowski
Update on Multiple Myeloma
Dr. Daniel Sherbenou
Update on CAR-T therapy
Dr. Terry Fry
Update on AML/MDS & Bone marrow failure disorders
Dr. Mrinal Patnaik
Update on MPN & Coagulation disorders
Dr. Brandon McMahon
The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Colorado School of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Vishal Rana, MD, MSPH